Literature DB >> 34908941

Emotional Blunting, Cognitive Impairment, Bone Fractures, and Bleeding as Possible Side Effects of Long-Term Use of SSRIs.

Donatella Marazziti1, Federico Mucci1, Beniamino Tripodi1, Manuel Glauco Carbone1, Alessia Muscarella1, Valentina Falaschi1, Stefano Baroni1.   

Abstract

OBJECTIVE: Selective serotonin (5-HT) reuptake inhibitors (SSRIs) are amongst the most prescribed drugs worldwide not only for psychiatric conditions, but also for medical purposes. Converging data gathered throughout the decades following their development would indicate that SSRIs have a broader side effect profile than previously assumed. Therefore, the aim of the present paper was to to review available literature highlighting less common side effects emerging with their long-term use.
METHOD: This systematic review, carried out according to PRISMA guidelines, was performed through searching electronic databases of PubMed, Google Scholar, Cochrane Library, Embase, MEDLINE, PsycINFO and Scopus. The keyword used was "SSRIs" combined with the following: "Side effects", or "Emotional blunting or flattening", or "Cognition", or "Neuroimaging", or "Bone", "or "Platelet aggregation", or "Bleeding".
RESULTS: The most common side effects, besides the classical ones described in the literature are represented by decreased emotional response to both adversive and pleasurable events, some cognitive impairments, bone fractures and prolonged overall bleeding time.
CONCLUSIONS: After analyzing critically the available findings, it should be noted that only the so-called "emotional blunting" is supported by converging data, while results on cognitive impairment are extremely controversial, given some evidence showing that SSRIs may improve cognition. Similarly, no agreement exists on the detrimental effects of SSRIs on bone metabolism and coagulation.Large, prospective and long-term studies are needed to clarify the possible impact of SSRIs on emotions, cognitive functions, bone fractures and coagulation, as well to detect other possible still neglected side effects.
© 2019 Giovanni Fioriti Editore s.r.l.

Entities:  

Keywords:  antidepressants; bone metabolism; chronic use; coagulation; cognition; emotional blunting; neuroimaging; selective serotonin reuptake inhibitors; side effects

Year:  2019        PMID: 34908941      PMCID: PMC8650205     

Source DB:  PubMed          Journal:  Clin Neuropsychiatry        ISSN: 1724-4935


  143 in total

1.  Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.

Authors:  Ixchel Herrera-Guzmán; Jorge E Herrera-Abarca; Esteve Gudayol-Ferré; Daniel Herrera-Guzmán; Lizbeth Gómez-Carbajal; Miriam Peña-Olvira; Erwin Villuendas-González; Guàrdia-Olmos Joan
Journal:  Psychiatry Res       Date:  2010-04-10       Impact factor: 3.222

2.  Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression.

Authors:  Esther Gómez-Gil; Cristóbal Gastó; Maribel Díaz-Ricart; Marta Carretero; Manel Salamero; Rosa Catalán; Ginés Escolar
Journal:  Hum Psychopharmacol       Date:  2002-12       Impact factor: 1.672

3.  SSRI-Induced Indifference.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2010-10

Review 4.  Inflammation, serotonin and major depression.

Authors:  Mario Catena-Dell'Osso; Francesco Rotella; Adriana Dell'Osso; Andrea Fagiolini; Donatella Marazziti
Journal:  Curr Drug Targets       Date:  2013-05-01       Impact factor: 3.465

5.  Cortisol hypersecretion and cognitive impairment in depression.

Authors:  D R Rubinow; R M Post; R Savard; P W Gold
Journal:  Arch Gen Psychiatry       Date:  1984-03

6.  A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure.

Authors:  Vijay K Yadav; Franck Oury; Nina Suda; Zhong-Wu Liu; Xiao-Bing Gao; Cyrille Confavreux; Kristen C Klemenhagen; Kenji F Tanaka; Jay A Gingrich; X Edward Guo; Laurence H Tecott; J John Mann; Rene Hen; Tamas L Horvath; Gerard Karsenty
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

Review 7.  Depression and Disturbed Bone Metabolism: A Narrative Review of the Epidemiological Findings and Postulated Mechanisms.

Authors:  J D Rosenblat; J M Gregory; A F Carvalho; R S McIntyre
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

8.  Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina.

Authors:  E P McFadden; J G Clarke; G J Davies; J C Kaski; A W Haider; A Maseri
Journal:  N Engl J Med       Date:  1991-03-07       Impact factor: 91.245

9.  Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate.

Authors:  X Henry Hu; Scott A Bull; Enid M Hunkeler; Eileen Ming; Janelle Y Lee; Bruce Fireman; Leona E Markson
Journal:  J Clin Psychiatry       Date:  2004-07       Impact factor: 4.384

Review 10.  Treating Chronic Pain with SSRIs: What Do We Know?

Authors:  Elias Patetsos; Emilia Horjales-Araujo
Journal:  Pain Res Manag       Date:  2016-07-03       Impact factor: 3.037

View more
  1 in total

1.  Emotional blunting in patients with depression. Part II: relationship with functioning, well-being, and quality of life.

Authors:  Michael Cronquist Christensen; Hongye Ren; Andrea Fagiolini
Journal:  Ann Gen Psychiatry       Date:  2022-06-20       Impact factor: 3.301

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.